Similar to CARM1 knockdown, 6-AN treatment effectively inhibited the proliferation of gastric cancer cells under low glucose conditions and was accompanied by substantial decreases in the levels of NADPH (Fig. S8A). Here, CARM1 is linked to gastric cancer.